Check out how much of the $ goes to the area IPIX is
Check out how much of the $ goes to the area IPIX is holding a possible inside straight! Living near the epi-center and having an inside personal source through the "RN grapevine" via nurses I proctored in Seattle/Kirkland/CWH here in WA State, this situation is worse than most media are just now realizing. I highly encourage all to not take it lightly as human nature tends when it is out of sight. Rural does not gurantee safety once it surfaces in any area. We need B available STAT if the science keeps its track record. As has been addressed, even as an adjunctive to the treatment with a vaccine and/or those that already have been infected. As this link shows, the $ is there for this to jump warp speed in tests. I know through the years that many, if not most, true long investors are here for an even higher cause than the return on our investment. Lives are at a higher stake than ever.
!https://www.msn.com/en-us/news/us/heres-where-taxpayer-money-will-go-from-the-coronavirus-package-trump-just-signed/ar-BB10QJSb?li=BBnb7KB
6
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Key Opportunity for Coinbase Investors Investors holding Coinbase Global, Inc. (NASDAQ: COIN) securities may have a significant opportunity to participate in a class action lawsuit alleging serious violations of securities regulations. This opportunity arises from actions that took place during the specified Class Period. Investors are encouraged to evaluate their...
Continue Reading
BridGene Biosciences Raises Significant Funding BridGene Biosciences, Inc., renowned for its innovative approach in developing small molecule drugs, recently announced the completion of a substantial $28 million Series B+ financing round. This funding round was spearheaded by Bayland Capital, alongside notable contributions from GTJA Investment Group, Proxima Ventures,...
Continue Reading
NMD Pharma's Innovative Phase 2 Study with NMD670 NMD Pharma A/S, an ambitious clinical-stage biotech company, is making strides in the fight against neuromuscular diseases. They have officially begun their Phase 2a clinical trial of NMD670, a novel treatment aimed at addressing the challenges faced by patients with Charcot-Marie-Tooth (CMT) disease types 1 and 2. This...
Continue Reading
Introduction to Becker Milk Company's Financial Landscape Becker Milk Company Limited is making headlines with its financial results for the first half of its fiscal year. The latest report showcases their performance, reflecting on revenues and net income trends. Financial Highlights Overview Total revenues for the first six months reveal a detail-oriented insight into...
Continue Reading
Exciting New Flavor Launch from Mini Melts and 7-Eleven In an exciting collaboration, Mini Melts USA, a leader in premium beaded ice cream, has partnered with 7-Eleven, Inc. to introduce a new flavor reminiscent of the classic Blue Raspberry Slurpee. This innovative flavor captures the essence of the much-loved frozen drink, providing fans with a delightful and nostalgic...
Continue Reading
